A multi-trait epigenome-wide association study identified DNA methylation signature of inflammation among men with HIV
- PMID: 39488703
- PMCID: PMC11531128
- DOI: 10.1186/s13148-024-01763-2
A multi-trait epigenome-wide association study identified DNA methylation signature of inflammation among men with HIV
Abstract
Inflammation underlies many conditions causing excess morbidity and mortality among people with HIV (PWH). A handful of single-trait epigenome-wide association studies (EWAS) have suggested that inflammation is associated with DNA methylation (DNAm) among PWH. Multi-trait EWAS may further improve statistical power and reveal pathways in common between different inflammatory markers. We conducted single-trait EWAS of three inflammatory markers (soluble CD14, D-dimers and interleukin-6) in the Veterans Aging Cohort Study (n = 920). The study population was all male PWH with an average age of 51 years, and 82.3% self-reported as Black. We then applied two multi-trait EWAS methods-CPASSOC and OmniTest-to combine single-trait EWAS results. CPASSOC and OmniTest identified 189 and 157 inflammation-associated DNAm sites, respectively, of which 112 overlapped. Among the identified sites, 56% were not significant in any single-trait EWAS. Top sites were mapped to inflammation-related genes including IFITM1, PARP9 and STAT1. These genes were significantly enriched in pathways such as "type I interferon signaling" and "immune response to virus." We demonstrate that multi-trait EWAS can improve the discovery of inflammation-associated DNAm sites, genes and pathways. These DNAm sites might hold the key to addressing persistent inflammation in PWH.
Keywords: D-dimer; EWAS; HIV; IL-6; sCD14.
© 2024. The Author(s).
Conflict of interest statement
V.C.M. has received investigator-initiated research grants (to the institution) and consultation fees from Eli Lilly, Bayer, Gilead Sciences, Merck and ViiV.
Figures



Update of
-
A multi-trait epigenome-wide association study identified DNA methylation signature of inflammation among people with HIV.Res Sq [Preprint]. 2024 May 31:rs.3.rs-4419840. doi: 10.21203/rs.3.rs-4419840/v1. Res Sq. 2024. Update in: Clin Epigenetics. 2024 Nov 2;16(1):152. doi: 10.1186/s13148-024-01763-2. PMID: 38854093 Free PMC article. Updated. Preprint.
References
-
- Forsythe SS, McGreevey W, Whiteside A, et al. Twenty years of antiretroviral therapy for people living with HIV: global costs, health achievements economic benefits. Health Aff. 2019;38(7):1163–72. 10.1377/hlthaff.2018.05391. - PubMed
-
- Peterson TE, Baker JV. Assessing inflammation and its role in comorbidities among persons living with HIV. Curr Opin Infect Dis. 2019;32(1):8–15. 10.1097/qco.0000000000000510. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous